Follow Us:
Wednesday, August 10, 2022

Pfizer Inc.


Pfizer-BioNTech seek US OK for second COVID booster for 65 and older

March 16, 2022 6:44 pm

Pfizer-BioNTech filed an application with US regulators seeking emergency use authorization for a second booster shot of their Covid-19 vaccine for people aged 65 and older.

US considers lengthening gap between first 2 Covid shots to 8 weeks

February 05, 2022 1:52 pm

In the United States, the recommended interval between the first two shots of Pfizer's vaccine is three weeks and for Moderna's, four.

Pfizer vaccine for children under 5 may be available in US by February end, says report

February 01, 2022 1:54 pm

Coronavirus vaccines for children younger than 5 could be available as soon as end-February under a plan that would lead to the potential authorisation of a two-shot regimen in the coming weeks.

Explained: What is the process for Pfizer's Covid oral drug Paxlovid to come to India?

December 23, 2021 12:53 pm

Pfizer's Covid-19 antiviral drug Paxlovid has received emergency use authorisation in the United States. Several Indian drug manufacturers are already planning to manufacture the generic version on it.

Explained: How does Merck's Covid-19 pill compare to Pfizer's?

November 09, 2021 3:03 pm

Pfizer and Merck have developed experimental antiviral pills that have shown promising efficacy in trials of adults with Covid-19 who are at high risk of serious illness. Here is an explanation of the differences in the two pills.

Booster shots are less effective in people with weak immune systems: study

November 03, 2021 4:19 pm

To help immunocompromised people mount a more aggressive immune response, the CDC suggests that they be given three doses of Pfizer or Moderna vaccines, plus an additional booster shot six months after the third dose.

FDA panel backs Pfizer's low-dose Covid-19 vaccine for kids

October 27, 2021 7:55 am

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine’s benefits in preventing COVID-19 in that age group outweigh any potential risks.

J&J files for authorization of COVID-19 vaccine booster

October 05, 2021 4:59 pm

The filing comes after the FDA last week scheduled an Oct. 15 meeting of its expert advisory committee to discuss whether to authorize a second shot of J&J's single-dose vaccine.

US FDA authorizes third dose of Pfizer Covid-19 vaccine for older Americans

September 23, 2021 11:04 am

The booster dose is to be administered at least six months after completion of the second dose, and the authorization would include people most susceptible to severe disease and those in jobs that left them at risk, the FDA said.

New research: Comparing antibody levels in Moderna and Pfizer Covid-19 recipients

September 07, 2021 10:11 am

Moderna vs Pfizer: The findings are significant because these results mark another step towards scientists determining whether one Covid-19 vaccine may be superior for certain demographics.